tiprankstipranks
Trending News
More News >
Hold Rating for Tarsus Pharmaceuticals Amid Strong Sales and Market Uncertainties
PremiumRatingsHold Rating for Tarsus Pharmaceuticals Amid Strong Sales and Market Uncertainties
2M ago
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
Premium
The Fly
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
2M ago
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
Premium
Ratings
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
2M ago
Tarsus Pharmaceuticals: Strong Buy Rating Driven by Impressive Financial Performance and Strategic Growth Positioning
PremiumRatingsTarsus Pharmaceuticals: Strong Buy Rating Driven by Impressive Financial Performance and Strategic Growth Positioning
2M ago
Tarsus Pharmaceuticals reports Q4 EPS (60c), consensus (82c)
Premium
The Fly
Tarsus Pharmaceuticals reports Q4 EPS (60c), consensus (82c)
2M ago
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals
Premium
Ratings
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals
3M ago
Tarsus Pharmaceuticals price target raised to $73 from $61 at H.C. Wainwright
PremiumThe FlyTarsus Pharmaceuticals price target raised to $73 from $61 at H.C. Wainwright
5M ago
Tarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
5M ago
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100